Evidence map›Paper›PMID 24190514›Full record

ArticleLipids2014

Exogenous sphingosine 1-phosphate protects murine splenocytes against hypoxia-induced injury.

Sonam Chawla, Chayanika Sahni, Rajkumar Tulsawani, Mrinalini Singh, Deepika Saraswat, Anju Bansal, Shweta Saxena

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sonam ChawlaExperimental Biology Division, Defence Institute of Physiology and Allied Sciences (DIPAS), Ministry of Defence, Defence Research and Development Organisation (DRDO), Lucknow Road, Timarpur, Delhi, 110054, India.
Chayanika Sahni
Rajkumar Tulsawani
Mrinalini Singh
Deepika Saraswat
Anju Bansal
Shweta Saxena
Defence Research and Development Organisation · INMinistry of Defence · INAmity University · INDefence Institute of Physiology and Allied Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P), a biologically active pleiotropic lipid, is involved in several physiological processes especially in the area of vascular biology and immunology encompassing cell survival, angiogenesis, vascular tone, immune response etc. by interacting with specific cell surface receptors. Hypoxia, a condition common to innumerable pathologies, is known to lethally affect cell survival by throwing off balance global gene expression, redox homeostasis, bioenergetics etc. Several molecular events of cellular adaptations to hypoxia have been closely linked to stabilization of hypoxia inducible factor-1α (HIF-1α). Signalling functions of S1P in physiological events central to hypoxia-induced pathologies led us to investigate efficacy of exogenous S1P in preconditioning murine splenocytes to sustain during cellular stress associated with sub-optimal oxygen. The present study recapitulated the pro-survival benefits of exogenous S1P under normobaric hypoxia. Results indicate a direct effect of S1P supplementation on boosting cellular adaptive responses via HIF-1α stabilization and, activation of pro-survival mediators ERK and Akt. Overwhelming anti-oxidative and anti-inflammatory benefits of S1P preconditioning could also be captured in the present study, as indicated by improved redox homeostasis, reduced oxidative damage, balanced anti/pro-inflammatory cytokine profiles and temporal regulation of nitric oxide secretion and intra-cellular calcium release. Hypoxia induced cell death and the associated stress in cellular milieu in terms of oxidative damage and inflammation could be alleviated with exogenous S1P preconditioning.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsCells, CulturedCell SurvivalCytokinesHypoxiaHypoxia-Inducible Factor 1, alpha SubunitLysophospholipidsMAP Kinase Signaling SystemMiceMice, Inbred BALB COxidative StressProto-Oncogene Proteins c-aktSphingosineSpleenAnti-Inflammatory AgentsAntioxidantsCytokinesHypoxia-Inducible Factor 1, alpha SubunitLysophospholipidsProto-Oncogene Proteins c-aktSphingosinesphingosine 1-phosphate

Identifiers

PMID24190514
OpenAlexW2038952848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.